119 related articles for article (PubMed ID: 11788049)
1. beta-Amyloid peptide vaccination results in marked changes in serum and brain Abeta levels in APPswe/PS1DeltaE9 mice, as detected by SELDI-TOF-based ProteinChip technology.
Vehmas AK; Borchelt DR; Price DL; McCarthy D; Wills-Karp M; Peper MJ; Rudow G; Luyinbazi J; Siew LT; Troncoso JC
DNA Cell Biol; 2001 Nov; 20(11):713-21. PubMed ID: 11788049
[TBL] [Abstract][Full Text] [Related]
2. Duration and specificity of humoral immune responses in mice vaccinated with the Alzheimer's disease-associated beta-amyloid 1-42 peptide.
Dickey CA; Morgan DG; Kudchodkar S; Weiner DB; Bai Y; Cao C; Gordon MN; Ugen KE
DNA Cell Biol; 2001 Nov; 20(11):723-9. PubMed ID: 11788050
[TBL] [Abstract][Full Text] [Related]
3. Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory.
Arendash GW; Gordon MN; Diamond DM; Austin LA; Hatcher JM; Jantzen P; DiCarlo G; Wilcock D; Morgan D
DNA Cell Biol; 2001 Nov; 20(11):737-44. PubMed ID: 11788052
[TBL] [Abstract][Full Text] [Related]
4. Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer's disease.
Yang W; Chauhan A; Mehta S; Mehta P; Gu F; Chauhan V
Life Sci; 2014 Mar; 99(1-2):31-6. PubMed ID: 24486299
[TBL] [Abstract][Full Text] [Related]
5. Active immunization of mice with an Abeta-Hsp70 vaccine.
Koller MF; Mohajeri MH; Huber M; Wollmer MA; Roth Z'graggen BV; Sandmeier E; Moritz E; Tracy J; Nitsch RM; Christen P
Neurodegener Dis; 2004; 1(1):20-8. PubMed ID: 16908970
[TBL] [Abstract][Full Text] [Related]
6. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
[TBL] [Abstract][Full Text] [Related]
7. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.
Schenk D; Barbour R; Dunn W; Gordon G; Grajeda H; Guido T; Hu K; Huang J; Johnson-Wood K; Khan K; Kholodenko D; Lee M; Liao Z; Lieberburg I; Motter R; Mutter L; Soriano F; Shopp G; Vasquez N; Vandevert C; Walker S; Wogulis M; Yednock T; Games D; Seubert P
Nature; 1999 Jul; 400(6740):173-7. PubMed ID: 10408445
[TBL] [Abstract][Full Text] [Related]
8. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
[TBL] [Abstract][Full Text] [Related]
9. Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease.
Timmer NM; Herbert MK; Kleinovink JW; Kiliaan AJ; De Waal RM; Verbeek MM
Neuropathol Appl Neurobiol; 2010 Oct; 36(6):478-86. PubMed ID: 20831743
[TBL] [Abstract][Full Text] [Related]
10. Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice.
Santuccione AC; Merlini M; Shetty A; Tackenberg C; Bali J; Ferretti MT; McAfoose J; Kulic L; Bernreuther C; Welt T; Grimm J; Glatzel M; Rajendran L; Hock C; Nitsch RM
Mol Psychiatry; 2013 Mar; 18(3):358-68. PubMed ID: 22688190
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet.
Lemere CA; Beierschmitt A; Iglesias M; Spooner ET; Bloom JK; Leverone JF; Zheng JB; Seabrook TJ; Louard D; Li D; Selkoe DJ; Palmour RM; Ervin FR
Am J Pathol; 2004 Jul; 165(1):283-97. PubMed ID: 15215183
[TBL] [Abstract][Full Text] [Related]
12. Intranasal inoculation with an adenovirus vaccine encoding ten repeats of Aβ3-10 reduces AD-like pathology and cognitive impairment in Tg-APPswe/PSEN1dE9 mice.
Li Y; Ma Y; Zong LX; Xing XN; Guo R; Jiang TZ; Sha S; Liu L; Cao YP
J Neuroimmunol; 2012 Aug; 249(1-2):16-26. PubMed ID: 22626444
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer's Disease.
Petrushina I; Davtyan H; Hovakimyan A; Davtyan A; Passos GF; Cribbs DH; Ghochikyan A; Agadjanyan MG
Mol Ther; 2017 Jan; 25(1):153-164. PubMed ID: 28129111
[TBL] [Abstract][Full Text] [Related]
14. Altered APP processing in PDAPP (Val717 --> Phe) transgenic mice yields extended-length Abeta peptides.
Esh C; Patton L; Kalback W; Kokjohn TA; Lopez J; Brune D; Newell AJ; Beach T; Schenk D; Games D; Paul S; Bales K; Ghetti B; Castaño EM; Roher AE
Biochemistry; 2005 Oct; 44(42):13807-19. PubMed ID: 16229470
[TBL] [Abstract][Full Text] [Related]
15. Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice.
Chua LM; Lim ML; Chong PR; Hu ZP; Cheung NS; Wong BS
J Alzheimers Dis; 2012; 29(4):783-91. PubMed ID: 22337827
[TBL] [Abstract][Full Text] [Related]
16. Overcoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic mice.
Li Q; Cao C; Chackerian B; Schiller J; Gordon M; Ugen KE; Morgan D
BMC Neurosci; 2004 Jun; 5():21. PubMed ID: 15186505
[TBL] [Abstract][Full Text] [Related]
17. A modified preparation (LMK03) of the oriental medicine Jangwonhwan reduces Abeta(1-42) level in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease.
Seo JS; Jung EY; Kim JH; Lyu YS; Han PL; Kang HW
J Ethnopharmacol; 2010 Aug; 130(3):578-85. PubMed ID: 20669372
[TBL] [Abstract][Full Text] [Related]
18. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
[TBL] [Abstract][Full Text] [Related]
19. Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice.
Mably AJ; Liu W; Mc Donald JM; Dodart JC; Bard F; Lemere CA; O'Nuallain B; Walsh DM
Neurobiol Dis; 2015 Oct; 82():372-384. PubMed ID: 26215784
[TBL] [Abstract][Full Text] [Related]
20. Improving memory and decreasing cognitive impairment in Tg-APPswe/PSEN1dE9 mice with Aβ3-10 repeat fragment plasmid by reducing Aβ deposition and inflammatory response.
Ma Y; Li Y; Zong LX; Xing XN; Zhang WG; Cao YP
Brain Res; 2011 Jul; 1400():112-24. PubMed ID: 21658683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]